Reich Kristian

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Reich Kristian's trades of MoonLake Immunotherapeutics's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27
PlS Planned sale
30,680 +14.6%
77.17
US$1,190,542 		30,680 +14.6% 77.17 US$1,190,542
2026-07-23 2026-07-22
PlS Planned sale
86,907 +21.3%
360.33
US$1,401,821 		86,907 +21.3% 360.33 US$1,401,821
2026-07-23 2026-07-21
PlS Planned sale
31,373 -45.6%
56.08
US$2,509,189 		31,373 -45.6% 56.08 US$2,509,189
2026-07-21 2026-07-20
PlS Planned sale
43,700 -1.6%
20.09
US$877,933 		43,700 -1.6% 20.09 US$877,933
2026-07-20 2026-07-15
PlS Planned sale
16,105 -0.6%
20.01
US$322,261 		16,105 -0.6% 20.01 US$322,261
2026-07-15 2026-07-15
PrS Proposed sale
150,000
19.44
US$2,916,000 		150,000 19.44 US$2,916,000
2026-06-17 2026-06-17
PlS Planned sale
50,000 -1.7%
19.43
US$971,500 		50,000 -1.7% 19.43 US$971,500
2026-06-17 2026-06-16
PlS Planned sale
50,000 -1.7%
18.70
US$935,000 		50,000 -1.7% 18.70 US$935,000
2026-06-17 2026-06-15
PlS Planned sale
50,000 -1.7%
18.89
US$944,500 		50,000 -1.7% 18.89 US$944,500
2026-06-15 2026-06-15
PrS Proposed sale
150,000
19.00
US$2,850,000 		150,000 19.00 US$2,850,000
2025-12-10 2025-12-09
S Sale
72,908 -100.0%
14.43
US$1,052,062 		72,908 -100.0% 14.43 US$1,052,062
2025-12-10 2025-12-08
S Sale
130,000 -64.1%
15.08
US$1,960,400 		130,000 -64.1% 15.08 US$1,960,400
2025-12-08 2025-12-08
PrS Proposed sale
202,908
14.80
US$3,003,038 		202,908 14.80 US$3,003,038
2024-02-29 2024-02-28
PlS Planned sale
28,090 -40.1%
55.00
US$1,544,950 		28,090 -40.1% 55.00 US$1,544,950
2024-02-29 2024-02-28
PlS Planned sale
31,910 -1.1%
55.00
US$1,755,050 		31,910 -1.1% 55.00 US$1,755,050
2024-02-29 2024-02-27
PlS Planned sale
29,431 -29.6%
55.00
US$1,618,705 		29,431 -29.6% 55.00 US$1,618,705
2024-02-29 2024-02-27
PlS Planned sale
29,491 -1.0%
55.00
US$1,622,005 		29,491 -1.0% 55.00 US$1,622,005
2024-02-22 2024-02-21
PlS Planned sale
569 -0.6%
55.30
US$31,466 		569 -0.6% 55.30 US$31,466
2024-02-22 2024-02-21
PlS Planned sale
509 -0.0%
55.31
US$28,153 		509 -0.0% 55.31 US$28,153
2024-02-22 2024-02-20
PlS Planned sale
10,000 -9.1%
57.43
US$574,300 		10,000 -9.1% 57.43 US$574,300
2024-02-22 2024-02-20
PlS Planned sale
10,000 -0.3%
57.45
US$574,500 		10,000 -0.3% 57.45 US$574,500
2024-02-16 2024-02-16
PlS Planned sale
10,000 -8.3%
60.15
US$601,500 		10,000 -8.3% 60.15 US$601,500
2024-02-16 2024-02-16
PlS Planned sale
10,000 -0.3%
60.15
US$601,500 		10,000 -0.3% 60.15 US$601,500
2024-02-16 2024-02-15
PlS Planned sale
10,000 -7.7%
60.16
US$601,600 		10,000 -7.7% 60.16 US$601,600
2024-02-16 2024-02-15
PlS Planned sale
10,000 -0.3%
60.17
US$601,700 		10,000 -0.3% 60.17 US$601,700
2024-02-16 2024-02-14
PlS Planned sale
10,000 -7.1%
62.43
US$624,300 		10,000 -7.1% 62.43 US$624,300
2024-02-16 2024-02-14
PlS Planned sale
10,000 -0.3%
62.42
US$624,200 		10,000 -0.3% 62.42 US$624,200
2024-02-14 2024-02-14
PrS Proposed sale
200,000
63.01
US$12,602,000 		200,000 63.01 US$12,602,000